State-of-the-art and prescription strength.
La Roche-Posay, a bonafide titan of industry, has announced the launch of Effaclar Adapalene Gel 0.1% Acne Treatment – their latest retinoid acne treatment, now available over-the-counter.
The new product contains the topical retinoid adapalene, a prescription-strength retinoid that has only been available through a doctor until now.
Just like other retinoids, adapalene works to regulate skin cell turnover, improve textural issues and to brighten and even skin tone.
However, because adapalene works similar to other retinoids, it can also be used for the same concerns that one would use any other retinoid for; fine lines, wrinkles, and evening out skin tone.
In addition to this, La Roche-Posay is also launching My Skin Track PoreScan, their first skin analysis powered by artificial intelligence.
The AI-led scanner allows consumers to take a photograph of their face using their phone and receive a personalised analysis of their skin, with a count of the various signs the tool is tracking as well as an overall severity score, ranging from 0 to 4+, according to Allure.
Based on the results, the consumer instantly receives tips and a skin-care regimen recommendation developed for their specific skin concerns.
This will work in tandem with previous launches such as My Skin Track/UV and My Skin Track pH – except, this time, there will be a singular focus on pores.